Monoclonal Mouse anti‑Human TRPC5 Antibody (clone S67‑15, aa827‑845, IHC, IF, WB) LS‑C152694
Monoclonal Mouse anti‑Human TRPC5 Antibody (clone S67‑15, aa827‑845, IHC, IF, WB) LS‑C152694
Antibody:
TRPC5 Mouse anti-Human Monoclonal (aa827-845) (S67-15) Antibody
Application:
IHC, ICC, IF, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Overview
Antibody:
TRPC5 Mouse anti-Human Monoclonal (aa827-845) (S67-15) Antibody
Application:
IHC, ICC, IF, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Specifications
Description
TRPC5 antibody LS-C152694 is an unconjugated mouse monoclonal antibody to TRPC5 (aa827-845) from human. It is reactive with human, mouse and rat. Validated for ICC, IF, IHC and WB.
Target
Human TRPC5
Synonyms
TRPC5 | CCE2 | HTRP-5 | HTRP5 | Transient receptor protein 5 | TRP5 | TRP-5 | Trrp5
Reactivity
Human, Mouse, Rat
(tested or 100% immunogen sequence identity)
Clonality
IgG2b
Monoclonal
Conjugations
Unconjugated
Purification
Protein G purified
Specificity
This antibody recognizes human, mouse, and rat TrpC5.
Applications
- IHC (0.1 - 1 µg/ml)
- ICC (0.1 - 1 µg/ml)
- Immunofluorescence (1 - 10 µg/ml)
- Western blot (1 - 10 µg/ml)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, pH 7.4, 0.09% Sodium Azide, 50% Glycerol
Storage
Store at -20°C, stable for 1 year. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, ICC, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/27/2024